Education
About Us
Working with TipRanks
Follow Us
Divi's Laboratories Limited (IN:DIVISLAB)
:DIVISLAB
RESEARCH TOOLSreports
Total Valuation
Divi's Laboratories Limited has a market cap or net worth of ₹1.63T. The enterprise value is ₹1.50T.
Market Cap₹1.63T
Enterprise Value₹1.50T
Share Statistics
Divi's Laboratories Limited has 265,468,570 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding265,468,570
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Divi's Laboratories Limited’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 9.55%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)9.55%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee8.05M
Profits Per Employee1.64M
Employee Count9,741
Asset Turnover0.51
Inventory Turnover1.03
Valuation Ratios
The current PE Ratio of Divi's Laboratories Limited is 70.6. Divi's Laboratories Limited’s PEG ratio is ―.
PE Ratio70.6
PS Ratio0.00
PB Ratio0.00
Price to Fair Value6.98
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Divi's Laboratories Limited had revenue of 78.45B and earned 16.00B in profits. Earnings per share was 60.27.
Revenue78.45B
Gross Profit45.76B
Operating Income18.32B
Pretax Income21.63B
Net Income16.00B
EBITDA25.43B
Earnings Per Share (EPS)60.27
Cash Flow
In the last 12 months, operating cash flow was 1.94B and capital expenditures -684.70M, giving a free cash flow of 1.25B billion.
Operating Cash Flow1.94B
Free Cash Flow1.25B
Free Cash Flow per Share4.73
Dividends & Yields
Divi's Laboratories Limited pays an annual dividend of ₹30, resulting in a dividend yield of 0.49%
Dividend Per Share₹30
Dividend Yield0.49%
Payout Ratio34.56%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.86
52-Week Price Change27.48%
50-Day Moving Average6.63K
200-Day Moving Average6.07K
Relative Strength Index (RSI)29.51
Average Volume (3m)7.23K
Important Dates
Divi's Laboratories Limited upcoming earnings date is Nov 10, 2025, TBA (Confirmed).
Last Earnings DateAug 6, 2025
Next Earnings DateNov 10, 2025
Ex-Dividend DateJul 25, 2025
Financial Position
Divi's Laboratories Limited as a current ratio of 7.57, with Debt / Equity ratio of 0.03%
Current Ratio7.57
Quick Ratio5.08
Debt to Market Cap0.00
Net Debt to EBITDA-0.14
Interest Coverage Ratio610.67
Taxes
In the past 12 months, Divi's Laboratories Limited has paid 5.63B in taxes.
Income Tax5.63B
Effective Tax Rate0.26
Enterprise Valuation
Divi's Laboratories Limited EV to EBITDA ratio is 37.11, with an EV/FCF ratio of 365.73.
EV to Sales12.03
EV to EBITDA37.11
EV to Free Cash Flow365.73
EV to Operating Cash Flow74.83
Balance Sheet
Divi's Laboratories Limited has ₹37.31B in cash and marketable securities with ― in debt, giving a net cash position of -₹37.27B billion.
Cash & Marketable Securities₹37.31B
Total Debt―
Net Cash-₹37.27B
Net Cash Per Share-₹140.39
Tangible Book Value Per Share₹511.05
Margins
Gross margin is 56.05%, with operating margin of 23.35%, and net profit margin of 20.40%.
Gross Margin56.05%
Operating Margin23.35%
Pretax Margin27.57%
Net Profit Margin20.40%
EBITDA Margin32.42%
EBIT Margin27.61%
Analyst Forecast
The average price target for Divi's Laboratories Limited is ₹6,670.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹6,670.00
Price Target Upside8.76% Upside
Analyst ConsensusHold
Analyst Count8
Revenue Growth Forecast―
EPS Growth Forecast―